Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 6474.

https://doi.org/10.1182/blood-2024-209615

Published: 2024

Journal Articles

Extranodal NK/T-Cell Lymphoma in Latin America: A Retrospective Multinational Analysis of Clinical Features, Therapeutic Approaches and Outcomes from the Latin American Group of Lymphoproliferative Disorders (GELL)

Fabiola Valvert, Omar Eduardo Fernandez Vargas, Sally Paredes, Luís Alberto de Pádua Covas Lage, Luis Mario Villela Martinez, Jose Marcial Macias Abasto, Victoria Irigoin, Cesar Camilo Carias Alvado, Juan C Barrios, Brenda Lizeth Acosta Maldonado, Denisse Castro, Betty Ramos Condori, Juliana Pereira, Silvia Rivas-Vera, Brady Beltran, Luis Malpica

Blood (2024) 144 (Supplement 1): 4452.

https://doi.org/10.1182/blood-2024-211049

Published: 2024

Journal Articles

Plasmablastic Lymphoma: Experience from a Single Referral Center in Mexico

Lena Grissel Simental Legarda, Humberto Baldemar Castellanos Sinco, Alonso Hernandez, Josheline Goretti Ramirez Jaramillo, Gerardo Santigo Jimenez, Karen Yanel Eduardo Vázquez, Mariana Guízar, Juan Francisco Zazueta Pozos, Gilberto Israel Barranco Lampon, Adán Germán Gallardo-Rodríguez, Daniela De Jesus Perez Samano, Carlos Martínez Murillo, Jorge Luis García Solache, Zaira Karina Pacheco Martínez, Raquel Pacheco López, Luis Mario Villela Martinez

Blood (2024) 144 (Supplement 1): 6444.

https://doi.org/10.1182/blood-2024-206046

Published: 2024

Journal Articles

Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)

Blood (2024) 144 (Supplement 1): 7515.

https://doi.org/10.1182/blood-2024-208856

Published: 2024

Journal Articles

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Blood (2024) 144 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2024-211584

Published: 2024

Journal Articles

Refining Prognostication in Peripheral T Cell Lymphoma (PTCL): A Risk-Adapted Prognostic Model for Patients with Limited-Stage PTCL

Carolina Romero, Macarena Roa, Henry Idrobo, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela Martinez, Juliana Pereira, Ana Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson S Castro, Renata Lyrio R Baptista, Samuel S. Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leão Cordeiro De Farias, Yung Gonzaga, Laura Korin, Patricio Pereyra, Camila Peña, Maria Alejandra Torres Viera, Kelly Meza, Seisha Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Thais Fischer, Asaad Trabolsi, Jonathan H. Schatz, Swaminathan P Iyer, Ranjit Nair, Eduardo Edelman Saul, Casey Bermack, Jorge J. Castillo, Carmino De Souza, Eliana Miranda, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 983.

https://doi.org/10.1182/blood-2024-205295

Published: 2024

Journal Articles

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Blood (2024) 144 (Supplement 1): 6452.

https://doi.org/10.1182/blood-2024-198823

Published: 2024

Journal Articles

Clinical Features, Therapy Patterns and Survival Outcomes of Limited-Stage Peripheral T-Cell Lymphomas: A Cross-Continental Study

Juan Esteban Garcia-Robledo, Henry Quintero, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela Martinez, Juliana Pereira, Ana Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson S Castro, Renata Lyrio R Baptista, Samuel S. Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leão Cordeiro De Farias, Yung Gonzaga, Laura Korin, Patricio Pereyra, Camila Peña, Macarena Roa, Maria Alejandra Torres Viera, Kelly Meza, Seisha Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Thais Fischer, Asaad Trabolsi, Jonathan H. Schatz, Swaminathan P Iyer, Ranjit Nair, Eduardo Edelman Saul, Casey Bermack, Jorge J. Castillo, Carmino De Souza, Eliana Miranda, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2024-205881

Published: 2024

Journal Articles

Moral Distress and Burnout Among Hematologists in Mexico: Results of a National Survey

Rubí Alejandra A Orta-Martínez, Fernando J Medina-Olivares, Gregory Abel, Anna Revette, Amar H. Kelkar, Erica O Koranteng, Maria del Campo-Martinez, Efreen Montano Figueroa, Brenda Lizeth Acosta Maldonado, Efrain Aquino-Fernandez, Luis Mario Villela Martinez, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 5205.

https://doi.org/10.1182/blood-2024-208223

Published: 2024

Journal Articles

The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a Collaborative Study grupo De Estudio Latino-Americano De Linfoproliferativos (GELL) & T-Cell Brazil Project (TCBP)

Thais Fischer, Eliana Miranda, Juliana Pereira, Guilherme Duffles, Jamila Vaz Tavarez, Nelson S Castro, Rodrigo Santucci, Danielle Leão Cordeiro De Farias, Sergio Brasil, Claudio G Macedo, Carolina Colaco, Renata Lyrio R Baptista, Karin Z Cecyn, Davimar Bortucchi, Gilnara Fontinele Silva, Samir Nabhan, Patricia Giacon, Rony Schaffel, Natalia Pin Chuen Zing, Frederico Lisboa Nogueira, Ademar Dantas Cunha, Diego Vila Cle, Jose D Tadeu, Vera Figueiredo, Mateus Dalló Dal Pont, Rafael Gaiolla, Nelson Hamerschlak, Eduardo Flavio Oliveira Ribeiro, Abrahão Elias Hallack Neto, Maria Almeida Dias, Yung Gonzaga, Yana S Rabelo, Larissa Lane Teixeira, Guilherme Fleury Perini, Milene Matedi, Priscilla Cury, Henry Idrobo, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela Martinez, Ana Carolina Oliver, Laura Korin, Camila Peña, Macarena Roa, Maria Alejandra Torres, Seisha Alana von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino A Souza, Luis Malpica, Carlos Chiattone

Blood (2024) 144 (Supplement 1): 1692.

https://doi.org/10.1182/blood-2024-211164

Published: 2024

Journal Articles

Uncovering the Epidemiology, Therapy Patterns and Outcomes of MALT Lymphoma in Latin America: A Multinational Retrospective Cohort Study

Blood (2024) 144 (Supplement 1): 3718.

https://doi.org/10.1182/blood-2024-204266

Published: 2024

Journal Articles

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1748.

https://doi.org/10.1182/blood-2023-187049

Published: 2023

Journal Articles

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2023-188015

Published: 2023

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

Journal Articles

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 10918–10920.

https://doi.org/10.1182/blood-2022-168276

Published: 2022

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Perla R.R. Colunga-Pedraza, Andres Gomez-De Leon, Christianne Bourlon De Los Rios, Cesar Omar Vargas-Serafin, Myrna Patricia Pequeño Luevano, Lauro Fabian Amador, Carolina García-Castillo, Martha Alvarado, Guillermo José Ruiz-Argüelles, Alberto Olaya-Vargas, Samantha P. Peña-Lozano, Guadalupe González Villarreal, Elías Eugenio González López, Gabriela Cardoso Yah, Ivan Murrieta-Alvarez, Luis Mario Villela Martinez, David Gomez Almaguer

Blood (2022) 140 (Supplement 1): 5185–5187.

https://doi.org/10.1182/blood-2022-169096

Published: 2022

Journal Articles

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study Group in Lymphoma from a Database of 855 Patients

Luis Mario VILLELA Martinez, MD, Ana Ramirez-Ibarguen, MD, Efreen Montaño Figueroa, PhD, Montserrat Rojas-Sotelo, MD, Fernando Perez-Jacobo, MD, Gisela B. Gomez-Cruz, MD, Silvia Rivas-Vera, MD, Jorge Duque, MD, Sergio Tena, MD, Yocanxochitl Perfecto-Avalos, MS, Guillermo Ruiz Arguelles, MD, David Gomez-Almaguer, MD, Carlos Best, MD, Arianna Robles-Rodriguez, MD, Alicia Guzman

Blood (2018) 132 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2018-99-118411

Published: 2018

NARROW

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Extranodal NK/T-Cell Lymphoma in Latin America: A Retrospective Multinational Analysis of Clinical Features, Therapeutic Approaches and Outcomes from the Latin American Group of Lymphoproliferative Disorders (GELL)

Plasmablastic Lymphoma: Experience from a Single Referral Center in Mexico

Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Refining Prognostication in Peripheral T Cell Lymphoma (PTCL): A Risk-Adapted Prognostic Model for Patients with Limited-Stage PTCL

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Clinical Features, Therapy Patterns and Survival Outcomes of Limited-Stage Peripheral T-Cell Lymphomas: A Cross-Continental Study

Moral Distress and Burnout Among Hematologists in Mexico: Results of a National Survey

The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a Collaborative Study grupo De Estudio Latino-Americano De Linfoproliferativos (GELL) & T-Cell Brazil Project (TCBP)

Uncovering the Epidemiology, Therapy Patterns and Outcomes of MALT Lymphoma in Latin America: A Multinational Retrospective Cohort Study

Real-World Data on the Clinical Features, Therapy Patterns and Outcomes of 651 Elderly Patients with Diffuse Large B-Cell Lymphoma in Latin America: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study Group in Lymphoma from a Database of 855 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only